Cheng AS - Search Results

1

The Janus face of cathelicidin in tumorigenesis.

Wu WK, Sung JJ, Cheng AS, Chan FK, Ng SS, To KF, Wang XJ, Zhang L, Wong SH, Yu J, Cho CH. Wu WK, et al. Among authors: cheng as. Curr Med Chem. 2014;21(21):2392-400. doi: 10.2174/0929867321666140205135351. Curr Med Chem. 2014. PMID: 24524763 Review.

2

Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy.

Cheng AS, Chan HL, Leung NW, Liew CT, To KF, Lai PB, Sung JJ. Cheng AS, et al. Aliment Pharmacol Ther. 2002 Feb;16(2):251-60. doi: 10.1046/j.1365-2036.2002.01163.x. Aliment Pharmacol Ther. 2002. PMID: 11860408 Free article.

3

Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.

Cheng AS, Chan HL, Leung WK, Wong N, Johnson PJ, Sung JJ. Cheng AS, et al. Int J Oncol. 2003 Jul;23(1):113-9. Int J Oncol. 2003. PMID: 12792783

4

Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.

Cheng AS, Chan HL, To KF, Leung WK, Chan KK, Liew CT, Sung JJ. Cheng AS, et al. Int J Oncol. 2004 Apr;24(4):853-60. Int J Oncol. 2004. PMID: 15010822

5

Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2.

Cheng AS, Chan HL, Leung WK, To KF, Go MY, Chan JY, Liew CT, Sung JJ. Cheng AS, et al. Mod Pathol. 2004 Oct;17(10):1169-79. doi: 10.1038/modpathol.3800196. Mod Pathol. 2004. PMID: 15218507 Free article.

6

Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis.

Yu J, Hui AY, Chu ES, Cheng AS, Go MY, Chan HL, Leung WK, Cheung KF, Ching AK, Chui YL, Chan KK, Sung JJ. Yu J, et al. Among authors: cheng as. Gut. 2007 Jul;56(7):991-9. doi: 10.1136/gut.2006.097923. Epub 2006 Dec 5. Gut. 2007. PMID: 17148503 Free PMC article.

7

RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma.

Cheng AS, Wong N, Tse AM, Chan KY, Chan KK, Sung JJ, Chan HL. Cheng AS, et al. Cancer Lett. 2007 Aug 8;253(1):43-52. doi: 10.1016/j.canlet.2007.01.004. Epub 2007 Feb 12. Cancer Lett. 2007. PMID: 17296261

8

Targeted inhibition of COX-2 expression by RNA interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells.

Chan MW, Wong CY, Cheng AS, Chan VY, Chan KK, To KF, Chan FK, Sung JJ, Leung WK. Chan MW, et al. Among authors: cheng as. Oncol Rep. 2007 Dec;18(6):1557-62. Oncol Rep. 2007. PMID: 17982644

9

Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice.

Yu J, Wu CW, Chu ES, Hui AY, Cheng AS, Go MY, Ching AK, Chui YL, Chan HL, Sung JJ. Yu J, et al. Among authors: cheng as. Biochem Biophys Res Commun. 2008 Aug 8;372(4):571-7. doi: 10.1016/j.bbrc.2008.05.069. Epub 2008 May 27. Biochem Biophys Res Commun. 2008. PMID: 18503750

10

COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis.

Cheng AS, Yu J, Lai PB, Chan HL, Sung JJ. Cheng AS, et al. Biochem Biophys Res Commun. 2008 Sep 19;374(2):175-80. doi: 10.1016/j.bbrc.2008.06.098. Epub 2008 Jul 2. Biochem Biophys Res Commun. 2008. PMID: 18601905

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters